Could a diabetes pill also calm psoriasis? new study aims to find out

NCT ID NCT07401992

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding semaglutide (a drug used for diabetes and weight loss) to a standard topical cream can improve psoriasis symptoms and reduce body-wide inflammation. About 62 adults with plaque psoriasis who are overweight or have type 2 diabetes will receive either semaglutide pills or placebo for 12 weeks, along with the cream. Researchers will measure skin clearing, quality of life, and blood markers of inflammation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Universitario Dr. José E. González

    RECRUITING

    Monterrey, N.L., 64460, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.